This issue of Clinics in Chest Medicine, guest-edited by Dr. Gerard Criner and Dr. Bartolome Celli, is focused on Chronic Obstructive Pulmonary Disease. Topics discussed in this issue include but are not limited to: COPD Pathogenesis; Epidemiology of COPD; Host, Gender, and Early Life Factors as Risks for COPD; Alpha One Antitrypsin Deficiency; Lung Function Testing; Assessing Symptom Burden; Chest Imaging in the Diagnosis and Assessment of the Patient with COPD; Biomarkers in the Diagnosis and Assessment of COPD; Asthma/COPD Overlap; Multimorbidity in the Patient with COPD; Definition Causes, Pathogenesis, and Consequences of Exacerbations; Treatment of Acute Exacerbations; Prevention of Exacerbations; Bronchodilators; Benefits and Risks of Inhaled Corticosteroids in COPD; Systemic Medications; Smoking Cessation/Vaccinations; Pulmonary Rehabilitation; Oxygen Therapy/Noninvasive Ventilation; and Interventional and Surgical Therapies for COPD.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Clinics in Chest Medicine - p. xiii 7. Preface - p. xv 8. Section I: COPD pathogenesis and risk factors - p. xvii 9. Chronic Obstructive Pulmonary Disease Pathogenesis - p. 307 10. Epidemiology of Chronic Obstructive Pulmonary Disease - p. 315 11. Host, Gender, and Early-Life Factors as Risks for Chronic Obstructive Pulmonary Disease - p. 329 12. Alpha-1 Antitrypsin Deficiency Associated COPD - p. 339 13. Section II: Diagnosis and Assessment of COPD - p. 345 14. Lung Function Testing in Chronic Obstructive Pulmonary Disease - p. 347 15. Assessing Symptom Burden - p. 367 16. Computerized Chest Imaging in the Diagnosis and Assessment of the Patient with Chronic Obstructive Pulmonary Disease - p. 375 17. Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine - p. 383 18. What Is Asthma Chronic Obstructive Pulmonary Disease Overlap? - p. 395 19. Multimorbidity in Patients with Chronic Obstructive Pulmonary Disease - p. 405 20. Section III: Exacerbations - p. 419 21. Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations - p. 421 22. Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease - p. 439 23. Prevention of Chronic Obstructive Pulmonary Disease - p. 453 24. Section IV: Pharmacologic Therapy in COPD - p. 462 25. Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease: Which One(S), How, and When? - p. 463 26. Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Benefits and Risks - p. 475 27. Systemic Medications in Chronic Obstructive Pulmonary Disease: Use and Outcomes - p. 485 28. Section V: Non-pharmacological therapy in COPD - p. 494 29. Smoking Cessation/Vaccinations - p. 495 30. Pulmonary Rehabilitation - p. 513 31. Oxygen Therapy and Noninvasive Ventilation in Chronic Obstructive Pulmonary Disease - p. 529 32. Interventional Bronchoscopic Therapies for Chronic Obstructive Pulmonary Disease - p. 547 33. Surgical Therapies for Chronic Obstructive Pulmonary Disease - p. 559
This issue of Clinics in Chest Medicine, guest-edited by Dr. Gerard Criner and Dr. Bartolome Celli, is focused on Chronic Obstructive Pulmonary Disease. Topics discussed in this issue include but are not limited to: COPD Pathogenesis; Epidemiology of COPD; Host, Gender, and Early Life Factors as Risks for COPD; Alpha One Antitrypsin Deficiency; Lung Function Testing; Assessing Symptom Burden; Chest Imaging in the Diagnosis and Assessment of the Patient with COPD; Biomarkers in the Diagnosis and Assessment of COPD; Asthma/COPD Overlap; Multimorbidity in the Patient with COPD; Definition Causes, Pathogenesis, and Consequences of Exacerbations; Treatment of Acute Exacerbations; Prevention of Exacerbations; Bronchodilators; Benefits and Risks of Inhaled Corticosteroids in COPD; Systemic Medications; Smoking Cessation/Vaccinations; Pulmonary Rehabilitation; Oxygen Therapy/Noninvasive Ventilation; and Interventional and Surgical Therapies for COPD.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Clinics in Chest Medicine - p. xiii 7. Preface - p. xv 8. Section I: COPD pathogenesis and risk factors - p. xvii 9. Chronic Obstructive Pulmonary Disease Pathogenesis - p. 307 10. Epidemiology of Chronic Obstructive Pulmonary Disease - p. 315 11. Host, Gender, and Early-Life Factors as Risks for Chronic Obstructive Pulmonary Disease - p. 329 12. Alpha-1 Antitrypsin Deficiency Associated COPD - p. 339 13. Section II: Diagnosis and Assessment of COPD - p. 345 14. Lung Function Testing in Chronic Obstructive Pulmonary Disease - p. 347 15. Assessing Symptom Burden - p. 367 16. Computerized Chest Imaging in the Diagnosis and Assessment of the Patient with Chronic Obstructive Pulmonary Disease - p. 375 17. Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine - p. 383 18. What Is Asthma Chronic Obstructive Pulmonary Disease Overlap? - p. 395 19. Multimorbidity in Patients with Chronic Obstructive Pulmonary Disease - p. 405 20. Section III: Exacerbations - p. 419 21. Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations - p. 421 22. Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease - p. 439 23. Prevention of Chronic Obstructive Pulmonary Disease - p. 453 24. Section IV: Pharmacologic Therapy in COPD - p. 462 25. Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease: Which One(S), How, and When? - p. 463 26. Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Benefits and Risks - p. 475 27. Systemic Medications in Chronic Obstructive Pulmonary Disease: Use and Outcomes - p. 485 28. Section V: Non-pharmacological therapy in COPD - p. 494 29. Smoking Cessation/Vaccinations - p. 495 30. Pulmonary Rehabilitation - p. 513 31. Oxygen Therapy and Noninvasive Ventilation in Chronic Obstructive Pulmonary Disease - p. 529 32. Interventional Bronchoscopic Therapies for Chronic Obstructive Pulmonary Disease - p. 547 33. Surgical Therapies for Chronic Obstructive Pulmonary Disease - p. 559
